Is it possible to end AIDS as a public health threat by 2030?

The United Nations thinks so and the guests on this podcast series certainly hope so but it's going to

take effort innovation connections between people and within communities and

funding welcome to can we end epidemics a podcast series by the Global Bio Pharmaceutical Company,

Vieve Healthcare, in association with its bio-farmer majority shareholder, GSK, and developed

by FP Studios. I'm Henry Bonnstu.

In this episode we ask our guest today are busy trying to

deliver health impact at scale. This is something that our

guests today are busy trying to address through their work with Amref and

G. S.K.

How can we build resilient systems to improve public health

and eliminate infectious disease by 2030 and beyond?

Let's see what they have to say. Dr. Mercy

Mongani is director of health systems strengthening it at Amreth Health Africa

and the former Chief Administrative Secretary for Kenya's Ministry of Health.

And Fiona Smith Leighton is Vice President and head of GSK's global health strategy and impact.

Welcome to both of you. Thank you. So Dr Mercy let's start off with the

partnership Ambreth Health Africa and G.S.K launched to improve treatment and

diagnosis rates in Ethiopia and Kenya

vis-à-vis malaria and TB over a two-year program.

How's that been going?

Thanks Henry, so our partnership with GSC includes improving

...